Dr Mohamed Bouattour

Spécialité

Onco-hépatologie (thématique, carninome hépatocellulaire, cholangiocarcinome, cancers hépatiques rare)

Hôpital

Hôpital Beaujon (Clichy)

Derniers articles

• The "A-B-C" classification reveals outcome trajectories in patients with hepatocellular carcinoma under atezolizumab/bevacizumab. (25 nov. 2025)
• Serum Procalcitonin: A Novel Tumor Biomarker for Diagnosis and Follow-Up in Fibrolamellar Hepatocellular Carcinoma. (20 nov. 2025)
• Palliative Care Referral Practices and Impact on Survival of Patients Diagnosed With Advanced Hepatocellular Carcinoma. (1 nov. 2025)
• Correction: ESR Bridges: imaging and treatment of uncommon liver tumours-a multidisciplinary view. (17 oct. 2025)
• PSMA immunohistochemistry as a diagnostic biomarker of hepatocellular carcinoma. (31 juil. 2025)